New Delhi India], May 24 (ANI): The feature for on-site registration and appointment is now being enabled for the 18-44 years age group on CoWIN, the Ministry of Health and Family Welfare informed on Monday.
New Delhi [India], May 24 (ANI): India crossed a significant landmark in its fight against the COVID-19 pandemic after the cumulative number of coronavirus vaccine doses for the 18-44 age group under Phase-3 of the vaccination drive administered in the country crossed one crore on Monday,
Mumbai (Maharashtra) [India], May 23 (ANI): Maharashtra Chief Minister Uddhav Thackeray on Sunday said that the COVID inoculation drive for the 18-44 age group has been suspended in the state as the supply of vaccines is not smooth.
Raipur (Chhattisgarh) [India], May 23 (ANI): Chhattisgarh Health Minister TS Singh Deo on Sunday said that the state is issuing vaccination certificates with the photograph of Chief Minister Bhupesh Baghel as the state is funding the vaccination drive for the beneficiaries of 18-44 years
Bengaluru (Karnataka) [India], May 23 (ANI): COVID-19 vaccination drive for the 18-44 age group has been halted in Karnataka, with the state government categorically saying the vaccines for the beneficiary category are "currently not available".
New Delhi [India], May 22 (ANI): Delhi Chief Minister Arvind Kejriwal on Saturday said that COVID-19 vaccination for the 18-44 age group will be halted from today in the national capital as the vaccine stock for the category has been consumed.
New Delhi [India], May 20 (ANI): Delhi has less than a day's stock of COVID-19 vaccine Covishield left for the 18-44 age group, according to Aam Aadmi Party (AAP) MLA Atishi Marlena.
New Delhi [India], May 19 (ANI/SRV Media): Dr. Dad is a Delhi-based startup that provides child-health related services and products. Founded by serial entrepreneur Dr. Gaurav Nigam, Dr. Dad is on a mission to revolutionise the way child-health related services are offered in India. The i
New Delhi [India], May 19 (ANI): The Delhi High Court on Wednesday refused to put an interim stay on Phase 2-3 clinical trials of Covaxin COVID-19 vaccine for the 2-18 age group.
New Delhi [India], May 18 (ANI): A Public Interest Litigation (PIL) has been moved in Delhi High Court seeking quashing of Centre's "notification" of May 13, which has accorded permission for conduct of phase two/three clinical trials of Covaxin in the age group 2 to 18 years to its manuf
New Delhi [India], May 18 (ANI): Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.
New Delhi [India], May 17 (ANI): As many as 59,32,704 beneficiaries of age group 18-44 years received their first dose of COVID vaccine across 36 states and UTs since phase 3 of vaccination began on May 1, the Union Health Ministry said on Monday.